17th April 2014
Daniel Ghinn provides an update on pharma's use of Pinterest since he last wrote about it two years ago. He updates us on the pharma companies who have adopted this... Read more
16th April 2014
Attending the Boehringer Ingelheim annual press conference, Paul Tunnah took the opportunity to catch up with its head of sales and marketing, Allan Hillgrove, to understand what is behind the... Read more
16th April 2014
Daniel Sanchez and Yin Ho explore the concept of cycle time in regulatory decisions in the pharma industry and their significance in market access. They consider the FDA compared with... Read more
15th April 2014
Luke Sewell highlights the burden of Western diseases such as cancer, diabetes and obesity on Latin America in pharmaphorum's emerging markets themed month.How Western diseases are impacting Latin AmericaThe disease... Read more
17th April 2014
NHS England is to spend £18.7 million to make new Hepatitis C treatment Sovaldi available to patients with the most advanced disease.Around 500 patients who have acute liver failure, and/or... Read more
16th April 2014
GlaxoSmithKline has gained FDA approval for its new diabetes treatment Tanzeum.The drug is the latest contender in the GLP-1 class of diabetes treatments, and is taken once a week for... Read more
16th April 2014
Boehringer Ingelheim announces flat growth for 2013 and anticipates a tough 2014, but pins future growth on aggressive R&D investment delivering more than 10 new product launches by 2016, to... Read more
15th April 2014
A leading charity says new Hepatitis C drug Sovaldi is a huge step forward in treating the disease – but says its high price means it is not affordable for... Read more
To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more
The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more
In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more
Watch the full round table video debate on 'oncology shaping the... View more
Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the... View info
The pharmaceutical industry is waking up to the enormous potential offered by social media and other online data sources for informing better decisions around drug development and commercialization. Here, Siva... View info
As pharmaceutical companies all look to step up their digital capabilities, this survey of digital leaders from across big pharma, exclusively first published on pharmaphorum, reveals an interesting picture of... View info
Empowered patients, or citizen experts as they are often called, are becoming one of the most powerful forces in healthcare, which means the pharmaceutical industry must learn to effectively engage... View info
In pharmaphorum's emerging markets themes month, Salil Kallianpur questions the importance of the emerging markets t... Read more
John Ansell shows how much better the products launched a decade ago have performed than expected at the time, an... Read more
In the concluding part of this two-part article exploring the drug pricing environment in Spain, Beatriz Casado and ... Read more
In part one of this two-part article exploring the drug pricing environment in Spain, Beatriz Casado and Kathrine Ka... Read more
New data on AbbVie's three-pronged Hepatitis C treatment shows the combination helped patients whose infectio... Read more
This article looks at the pharmaceutical market in Thailand in pharmaphorum's emerging market themed month.
Read more
Website and content copyright © 2009-2014, pharmaphorum media limited or its licensors; all rights reserved.
The rights of trade mark owners are acknowledged.
Strategic Internet Consulting, Digital Marketing Agency
